Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 21.4T | 18.4T | 24.5T | 24.0T |
Cost of revenue | 17.8T | 15.4T | 20.5T | 19.2T |
Gross profit | 3.7T | 3.0T | 4.0T | 4.8T |
Operating expense | ||||
Research & development | 1.5T | 1.3T | 1.2T | 990.6B |
Selling general and admin | 1.3T | 1.2T | 1.3T | 1.1T |
Other operating expenses | — | — | — | — |
Operating income | 880.0B | 470.1B | 1.5T | 2.6T |
Non operating interest income | ||||
Income | 373.8B | 381.4B | 421.4B | 409.0B |
Expense | 82.0B | 86.8B | 91.5B | 87.7B |
Other income expense | 305.1B | -203.1B | 791.4B | -309.9B |
Pretax income | 1.5T | 561.6B | 2.6T | 2.7T |
Tax provision | 342.3B | 161.1B | 413.8B | 573.0B |
Net income | 1.1T | 400.4B | 2.2T | 2.1T |
Basic EPS | 0.4 | 0.1 | 0.7 | 0.7 |
Diluted EPS | 0.3 | 0.1 | 0.7 | 0.6 |
Basic average shares | 3.1T | 3.1T | 3.1T | 3.0T |
Diluted average shares | 3.4T | 3.4T | 3.4T | 3.3T |
EBITDA | 2.9T | 2.1T | 4.2T | 4.1T |
Net income from continuing op. | 1.1T | 400.4B | 2.2T | 1.9T |
Minority interests | -17.2B | -10.5B | 22.9B | -15.3B |
Preferred stock dividends | — | 0 | — | 0 |